SIG
BIIB icon

Stanford Investment Group’s Biogen BIIB Stock Holding History

Stanford Investment Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-13
Closed -$4K – 31
2016
Q4 		$4K Hold
13
– – ﹤0.01% 338
2016
Q3 		$4K Hold
13
– – ﹤0.01% 372
2016
Q2 		$3K Hold
13
– – ﹤0.01% 337
2016
Q1 		$3K Hold
13
– – ﹤0.01% 336
2015
Q4 		$4K Hold
13
– – ﹤0.01% 304
2015
Q3 		$4K Hold
13
– – ﹤0.01% 311
2015
Q2 		$5K Sell
13
-67
-84% -$26.9K ﹤0.01% 312
2015
Q1 		$34K Sell
80
-10
-11% -$3.94K 0.03% 168
2014
Q4 		$31K Buy
+90
New +$29.1K 0.03% 185

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Stanford Investment Group's BIIB Position: Q1 2017 in Review

Stanford Investment Group sold out of Biogen (BIIB) in Q1 2017, closing a stake of 13 shares — an estimated $4K sold.

Stanford Investment Group first reported a position in BIIB in Q4 2014 and held it in 9 quarters. The position peaked at $34K in Q1 2015. 1,019 funds tracked by Wall St. Rank hold BIIB as of Q1 2017.

  • Stanford Investment Group reported no remaining Biogen position as of Q1 2017 after selling out during the quarter.
  • Stanford Investment Group sold 13 Biogen shares in Q1 2017, an estimated $4K.
  • Stanford Investment Group first reported a position in Biogen in Q4 2014 and held it in 9 quarters.
  • Stanford Investment Group's Biogen position peaked at $34K in Q1 2015.
  • 1,019 funds tracked by Wall St. Rank held Biogen as of Q1 2017.

Based on Stanford Investment Group's 13F filing for Q1 2017.